[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342410-105":59,"doc-detail-342410-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","rgd-p21ras-scfv-expressed-prokaryotically-on-a-pilot-scale-inhibits-ras-driven-colorectal-cancer-growth-by-blocking-p21ras-gtp","RGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer growth by blocking p21Ras-GTP","","Ras gene mutation and/or overexpression drive colorectal cancer progression, and interrupting Ras signaling is a key therapeutic direction. The study builds on an earlier recombinant RGD-p21Ras-scFv construct by expressing RGD-p21Ras-scFv prokaryotically at pilot scale, then evaluating anti-tumor efficacy and the molecular basis of Ras blockade. E. coli expression, purification, binding assays, signaling pathway analyses, and nude mouse xenograft testing are used to characterize potency and mechanism.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rgd-p21ras-scfv-expressed-prokaryotically-on-a-pilot-scale-inhibits-ras-driven-colorectal-cancer-growth-by-blocking-p21ras-gtp/342410/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rgd-p21ras-scfv-expressed-prokaryotically-on-a-pilot-scale-inhibits-ras-driven-colorectal-cancer-growth-by-blocking-p21ras-gtp/342410.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of expressing RGD-p21Ras-scFv at pilot scale?","Question",{"text":112,"@type":113},"To produce RGD-p21Ras-scFv prokaryotically on a pilot scale and evaluate its anti-tumor effect and the mechanism by which it blocks Ras signaling.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was binding between RGD-p21Ras-scFv and p21Ras investigated?",{"text":117,"@type":113},"The study used ELISA for immunoreactivity testing, plus immunofluorescence colocalization and pull-down assays to determine localization and binding.",{"name":119,"@type":110,"acceptedAnswer":120},"What downstream effects were observed after blocking Ras signaling?",{"text":121,"@type":113},"The phosphorylation of downstream effectors in the MEK-ERK and PI3K-AKT pathways was downregulated, alongside reduced active p21Ras-GTP levels.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342410,1790216541,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Lin etal. BMC Cancer (2024) 24:71 BMC Cancer  \n[https://doi.org/10.1186/s12885-023-11686-5](https://doi.org/10.1186/s12885-023-11686-5)  \nRESEARCH Open Access  \nRGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer growth by blocking p21Ras-GTP  \nPeng Lin1,2†, Jing Qian1,2,3†, Cheng-Cheng Huang1,2†, Wen-Mang Xu2, Yuan-Yuan Wang2, Zi-Ran Gao2, Shi-Qi Zheng2,4, Peng Wang2, Da-Qi Jia2,4, Qiang Feng2* and Ju-Lun Yang2*  \nAbstract  \nBackground Ras gene mutation and/or overexpression are drivers in the progression of cancers, including colorectal cancer. Blocking the Ras signaling has become a significant strategy for cancer therapy. Previously, we constructed a recombinant scFv, RGD-p21Ras-scFv by linking RGD membrane-penetrating peptide gene with the anti-p21Ras scFv gene. Here, we expressed prokaryotically RGD-p21Ras-scFv on a pilot scale, then investigated the anti-tumor effect and the mechanism of blocking Ras signaling.  \nMethods The E. coli bacteria which could highly express RGD-p21Ras-scFv was screened and grown in 100 L fermentation tank to produce RGD-p21Ras-scFv on optimized induced expression conditions. The scFv was purified from E. coli bacteria using His Ni-NTA column. ELISA was adopted to test the immunoreactivity of RGD-p21Ras  \nscFv against p21Ras proteins, and the IC50 of RGD-p21Ras-scFv was analyzed by CCK-8 . Immunofluorescence colocalization and pull-down assays were used to determine the localization and binding between RGD-p21Ras-scFvand p21Ras. The interaction forces between RGD-p21Ras-scFv and p21Ras after binding were analyzed by molecular docking, and the stability after binding was determined by molecular dynamics simulations. p21Ras-GTP interaction was detected by Ras pull-down. Changes in the MEK-ERK /PI3K-AKT signaling paths downstream of Ras were detected by WB assays. The anti-tumor activity of RGD-p21Ras-scFv was investigated by nude mouse xenograft models.  \nResults The technique of RGD-p21Ras-scFv expression on a pilot scale was established. The wet weight of the harvested bacteria was 31.064 g/L, and 31.6 mg RGD-p21Ras-scFv was obtained from 1 L of bacterial medium. The purity of the recombinant antibody was above 85%, we found that the prepared on a pilot scale RGD-p21Ras-scFv could penetrate the cell membrane of colon cancer cells and bind to p21Ras, then led to reduce of p21Ras-GTP (active p21Ras) . The phosphorylation of downstream effectors MEK-ERK /PI3K-AKT was downregulated. In vivo antitumor activity assays showed that the RGD-p21Ras-scFv inhibited the proliferation of colorectal cancer cell lines.  \n†Peng Lin, Jing Qian and Chengcheng Huang have contributed equally to this work.  \n*Correspondence: Qiang Feng [feiniaonanfei@163.com](feiniaonanfei@163.com)[ ](feiniaonanfei@163.com)Ju-Lun Yang [yangjulun@sina.com](yangjulun@sina.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The)[. The](http://creativecommons.org/licenses/by/4.0/. The)[ ](http://creativecommons.org/licenses/by/4.0/. The)Creative Commons Public Do","cbCair4TmvxOe1I1","https://ap.wps.com/l/cbCair4TmvxOe1I1","pdf",4735374,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n# Keywords","[{\"question\":\"What is the main goal of expressing RGD-p21Ras-scFv at pilot scale?\",\"answer\":\"To produce RGD-p21Ras-scFv prokaryotically on a pilot scale and evaluate its anti-tumor effect and the mechanism by which it blocks Ras signaling.\"},{\"question\":\"How was binding between RGD-p21Ras-scFv and p21Ras investigated?\",\"answer\":\"The study used ELISA for immunoreactivity testing, plus immunofluorescence colocalization and pull-down assays to determine localization and binding.\"},{\"question\":\"What downstream effects were observed after blocking Ras signaling?\",\"answer\":\"The phosphorylation of downstream effectors in the MEK-ERK and PI3K-AKT pathways was downregulated, alongside reduced active p21Ras-GTP levels.\"}]","RGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer growth by blocking p21Ras-GTP | PDF",1790046486,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93761da7667fbc741897071667bf8e30.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cece91948d1e42bc0f2db859bff8167f.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a64b480778e911e4d3fd810b16571952.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7157ee69e898148006aa7e892a5a0060.webp",980,1306]